Scientists at Oregon Health & Science University, Stanford University, University of Valencia and IGENOMIX have discovered that chromosomal abnormalities in human embryos created for in vitro fertilization, or IVF, can be predicted within the first 30 hours of development at the cell-1 stage which results from the union of a female egg and male sperm.

Advancing the field of structural biology that underpins how things work in a cell, researchers have identified how proteins change their shape when performing specific functions.

Oregon Health & Science University has named a research building after the late Hildegard Lamfrom, Ph.D., who was one of the 20th’ century’s most influential and accomplished women in the emerging field of molecular biology during an exceptional career spanning four decades.

Mutations in the ALK gene were identified in the tumors of two leukemia patients, and laboratory studies indicated that leukemias harboring these mutations may respond to ALK inhibitors such as crizotinib and ceritinib, according to a study published in Cancer Research that was conducted by researchers with the Knight Cancer Institute at Oregon Health & Science University.

In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University.

Oregon Health & Science University and the Department of Energy’s Pacific Northwest National Laboratory in Richland, Washington, have joined forces to answer some of the world’s most complex biomedical questions.

A new study shows an “alarming rise” over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU).

Research published today in the Proceedings of the National Academy of Sciences (PNAS) demonstrates that technology invented by researchers at Oregon Health & Science University’s Casey Eye Institute can improve the clinical management of the leading causes of blindness.